Stocktoria

BioNexus Gene Lab Corp BGLC

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2020-03-11 · LEI

BioNexus Gene Lab Corp statistics & valuation

Market cap$5.0M
P / S0.7×
P / B0.6×
Net margin-40.2%
Return on equity-34.6%
FCF margin-25.3%
Return on capital-34%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
12.50% -194.10% 9.60% 5.60% -3.30% -26.90% -16.80% -40.20% 20182019202020212022202320242025
Gross margin (%)
13.50% 44.00% 15.10% 17.00% 11.50% 13.60% 13.60% 14.60% 20182019202020212022202320242025
Operating margin (%)
28.20% -217.20% 11.20% 7.90% -2.70% -26.50% -16.50% -39.90% 20182019202020212022202320242025
Return on equity (%)
1.70% -22.00% 16.40% 10.50% -5.30% -27.20% -19.20% -34.60% 20182019202020212022202320242025
Shares outstanding
74.6M 102.7M 171.2M 171.2M 14.5M 17.7M 18.0M 2.4M 20182019202020212022202320242025
Net debt ($)
20182019202020212022202320242025
Share buybacks ($)
20182019202020212022202320242025
Return on assets (%)
1.60% -20.00% 10.80% 7.80% -4.10% -23.10% -15.30% -32.30% 20182019202020212022202320242025
Free cash flow margin (%)
-110.40% -181.20% 1.20% 0.00% 5.00% -20.20% -24.40% -25.30% 20182019202020212022202320242025
Debt / equity (×)
20182019202020212022202320242025
EPS ($)
-$0.17 -$0.09 20182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin14.6%13.6%13.6%11.5%17.0%15.1%44.0%13.5%
Operating margin-39.9%-16.5%-26.5%-2.7%7.9%11.2%-217.2%28.2%
Net margin-40.2%-16.8%-26.9%-3.3%5.6%9.6%-194.1%12.5%
FCF margin-25.3%-24.4%-20.2%5.0%0.0%1.2%-181.2%-110.4%
Return on assets-32.3%-15.3%-23.1%-4.1%7.8%10.8%-20.0%1.6%
Return on equity-34.6%-19.2%-27.2%-5.3%10.5%16.4%-22.0%1.7%
Current ratio10.463.814.933.003.072.3717.1120.64

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.